In conclusion, the contemporary changes in IL-6, its receptors’ concentrations, and the consequent increased signal transduction, together with a high CCI score as a risk factor, are closely associated with mortality and unfavorable outcomes in COVID-19 infected patients. This evidence concerns the gene IL6 and COVID-19.